Neidio i'r cynnwys
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Uwch
  • VEGF-A and FLT-1 tumour gene e...
  • Dyfynnu hwn
  • Anfonwch hwn fel neges destun
  • E-bostio hwn
  • Argraffu
  • Allforio Cofnod
    • Allforio i RefWorks
    • Allforio i EndNoteWeb
    • Allforio i EndNote
  • Permanent link
VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy

VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy

Manylion Llyfryddiaeth
Prif Awduron: Brueckl, WM, Wirtz, R, Dimmler, A, Brunner, T, Klein, P, Hahn, E, Ficker, J, Wiest, G
Fformat: Journal article
Cyhoeddwyd: 2009
  • Daliadau
  • Disgrifiad
  • Eitemau Tebyg
  • Dangos Staff
Disgrifiad
Crynodeb:

Eitemau Tebyg

  • TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
    gan: Papadopoulos Thomas, et al.
    Cyhoeddwyd: (2007-08-01)
  • Development and Validation of a Simplified Prognostic Score in SCLC
    gan: Elodie Negre, MD, et al.
    Cyhoeddwyd: (2020-03-01)
  • Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
    gan: Jin Yujuan, et al.
    Cyhoeddwyd: (2023-05-01)
  • Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study
    gan: Jiaping Liu, et al.
    Cyhoeddwyd: (2024-06-01)
  • Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
    gan: Kana Hashimoto, MD, et al.
    Cyhoeddwyd: (2024-11-01)

Opsiynau Chwilio

  • Hanes Chwilio
  • Chwiliad Uwch

Canfod Mwy

  • Pori'r Catalog
  • Pori yn ôl y Wyddor
  • Archwiliwch Sianeli
  • Cronfeydd y Cwrs
  • Eitemau Newydd

Angen Help?

  • Awgrymiadau Chwilio
  • Gofynnwch i Lyfrgellydd
  • Cwestiynau Cyffredin